Can a Microneedle Patch Rewrite the First Step in Skin Cancer Treatment?
Medicus-owned SkinJect is putting a chemotherapy drug into dissolvable microneedles, targeting common non-melanoma skin cancers. The idea is lighter-touch than surgery, but the real test remains clinical evidence and regulatory review.